Sign in

CIK 0001178670 · Large accelerated filer

ALNYLAM PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ALNY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
770602661
Phone
(617) 551-8200
Business address
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
Former names
ALNYLAM PHARMACEUTICALS INC
Open-market buys, last 90 days
$543,126
in 2 filings
Open-market sales, last 90 days
$398,855
in 1 filing

Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-02-28 Garg Pushkal CMO & EVP Dev & Med Affairs Sale −91 $240.32 $22K 13,674
2025-02-28 Garg Pushkal CMO & EVP Dev & Med Affairs Sale −149 $241.51 $36K 13,525
2025-02-28 Garg Pushkal CMO & EVP Dev & Med Affairs Sale −352 $242.44 $85K 13,173
2025-02-28 Garg Pushkal CMO & EVP Dev & Med Affairs Sale −142 $243.23 $35K 13,031
2025-02-28 Garg Pushkal CMO & EVP Dev & Med Affairs Sale −69 $244.11 $17K 12,962
2025-02-28 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale −27 $236.51 $6K 12,854
2025-02-28 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale −21 $238.33 $5K 12,833
2025-02-28 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale −22 $239.18 $5K 12,811
2025-02-28 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale −48 $240.32 $12K 12,763
2025-02-28 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale −79 $241.51 $19K 12,684
2025-02-28 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale −187 $242.44 $45K 12,497
2025-02-28 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale −75 $243.23 $18K 12,422
2025-02-28 Fitzgerald Kevin Joseph CSO & EVP, Head of Research Sale −37 $244.11 $9K 12,385
2025-02-27 Greenstreet Yvonne Chief Executive Officer Option exercise +5,921 87,447
2025-02-27 Greenstreet Yvonne Chief Executive Officer Option exercise · Restricted Stock Units −5,921 5,921
2025-02-27 Poulton Jeffrey V. EVP, Chief Financial Officer Option exercise +1,908 34,694
2025-02-27 Poulton Jeffrey V. EVP, Chief Financial Officer Option exercise · Restricted Stock Units −1,908 1,908
2025-02-27 Tanguler Tolga EVP, Chief Commercial Officer Option exercise +1,667 14,858
2025-02-27 Tanguler Tolga EVP, Chief Commercial Officer Option exercise · Restricted Stock Units −1,667 1,666
2025-02-27 Garg Pushkal CMO & EVP Dev & Med Affairs Option exercise +1,908 13,897

Page 35 of 41 · 816 trades